RÉSUMÉ DIGEST
ACT 230 (SB 426) 2020 Regular Session Barrow
New law prohibits a health coverage plan delivered or issued for delivery in this state from
denying coverage for COVID-19 diagnostic and antibody testing and antiviral drugs when
ordered by a physician for the purpose of making clinical decisions or treating a patient
suspected of having COVID-19.
Requires any health coverage plan delivered or issued for delivery in this state to include
coverage for COVID-19 diagnostic and antibody testing and antiviral drugs.
Prohibits the application of annual deductibles, coinsurance, copayment, or any other
out-of-pocket or cost-sharing expense provisions until December 31, 2021. After December
31, 2021, these services may be subject to these cost-sharing requirements.
Defines "COVID-19", "COVID-19 diagnostic test", "COVID-19 antibody test", "COVID-19
antiviral drug or agent", and "health coverage plan".
New law is not applicable to a plan providing coverage for excepted benefits, limited benefit
health insurance plans, high deductible health plans authorized under federal law, and
short-term policies that have a term of less than 12 months.
Effective upon signature of the governor (June 11, 2020).
(Adds R.S. 22:1057)